TY  - GEN
AU  - Maykov,E B
AU  - Yuricheva,Yu A
AU  - Mironov,N Yu
AU  - Sokolov,S F
AU  - Golitsyn,S P
AU  - Rozenshtraukh,L V
AU  - Chazov,E I
TI  - [Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter]
SN  - 0040-3660
PY  - 2015///0428
KW  - Action Potentials
KW  - drug effects
KW  - Anti-Arrhythmia Agents
KW  - administration & dosage
KW  - Atrial Fibrillation
KW  - drug therapy
KW  - Atrial Flutter
KW  - Data Interpretation, Statistical
KW  - Dose-Response Relationship, Drug
KW  - Echocardiography
KW  - Electrocardiography, Ambulatory
KW  - Female
KW  - Heart
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Piperidines
KW  - Potassium Channels
KW  - metabolism
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; English Abstract; Journal Article
UR  - https://doi.org/10.17116/terarkh201587138-48
ER  -